NWBO Northwest Biotherapeutics Inc

$NWBO As many know, I’ve talked a lot of shit about management over the years, but today shows just how MASSIVE the manipulation by market makers and naked shorts really is. In my opinion, yesterday’s news was CONFIRMATION OF APPROVAL. Nearly 20 MILLION shares traded on the BEST NEWS SINCE ADVENT, and we’re STILL at $0.15? We should’ve been UP 30–50% MINIMUM. I believe shorts are DESPERATELY spending MILLIONS to keep us pinned here. Who knows if Monday brings the usual drop or more of the same, but I’m BUYING ALL I CAN NO MATTER WHAT TO TRY TO GET TO 4,000,000 SHARES! A company on the verge of a BREAKTHROUGH APPROVAL for a treatment with the potential to treat ALL SOLID TUMOR CANCERS is worth FAR MORE than $0.15. LFG!!!

$NWBO I just bought my first 125,000 shares. The Market does not understand the significance of this UK deal which changes everything. Any smart Short is getting out today. The others now just are spouting FUD and hoping. Your run is over bears. Sure you can manipulate for another several days perhaps, but you have had your time.

$NWBO very very IMHO Today’s PR is bigger than people realize. NHS Blood & Transplant — the UK government’s national apheresis and cell‑processing infrastructure — just announced they are actively supporting production of DCVax‑L, not “planning to,” not “considering,” but supporting production now, with expansion across England already being mapped out. This is the kind of operational move that only happens when a therapy is expected to be approved and scaled. NHSBT does not build national infrastructure for an experimental product unless regulators have signaled confidence. The PR explicitly states DCVax‑L is being supported for GBM and all solid tumors — meaning the UK is preparing the manufacturing backbone not just for the initial indication, but for the entire DCVax platform. Leeds and Oxford are already online. More NHSBT sites across England are planned. This is national‑level rollout behavior — not Phase I, not Phase II, not “maybe someday.” This is pre‑commercial positioning. And remember: NWBO’s MAA is already under MHRA review. Regulators do not allow NHSBT to stand up production pipelines unless the therapy is expected to move forward. This PR reads like the infrastructure phase that happens right before approval, not after. If MHRA were months away, NHSBT wouldn’t be onboarding leukapheresis, cell processing, and multi‑site expansion today. They’d wait. Instead, they’re building the system now — which strongly suggests the regulatory finish line is close. This is the first time the UK government has publicly acknowledged DCVax‑L as a therapy they are preparing to deliver across England. That’s not a small signal — that’s the kind of move that usually precedes a green light.

$NWBO Next shoe to drop is MHRA acceptance of ECA/RWD guidance. Approval will follow that.

$NWBO There is no way in the world that NWBO gets the keynote presentation at NHS conference without them knowing approval is right around the corner. It just wouldn’t happen. It’s coming that much is clear.

$NWBO NHSBT has never collaborated with a company who later was denied MHRA approval. Galapagos NV fell through, but before they even applied for approval. All others eventually were approved. We are finally at the finish line. Congrats to those who have chosen to stick around. The bears are about to finally be made fools of.

$NWBO This is really a continuation of my first post. I agree with 808 that the lastest news is confirmation of approval.

$NWBO this was much needed recognition from a UK gov agency that they are supporting the development of DCVax. This alleviates one of my concerns that corruption within MHRA was stalling progress.

$NWBO Okay, granted, I am getting ahead of myself, but not nearly as much as the Market realizes: Today's news opens the door wide for a UK FDA equivalent approval which opens the door wide for a European Union EMA approval which opens the door wide for an FDA approval. What's more is that this treatment can be applied to almost ANY form of Cancer. What's more is that this opens the door for many other types of treatments including Anti-Aging Treatments of many types. NWBO actually has a Treatment Platform not just one treatment or drug.

$NWBO Friends, we all know by now that the MHRA will approve DC Vax-L... we just need a little more time and patience... buckle up... and focus on the technology of the future... know what you’re holding... 🙏🙏🙏🧿🧿🧿🚀🚀🚀

$NWBO You've got to admit being involved with nwbo was initially a long shot. Science started to make it look like it might be real along the way. We've dealt with crazy accusations, some of which have been true, some of which have been b*****. The thing is though I'm still in this and have been long for quite some time. Along the way there have been times when I've been excited only to be let down over and over again. New announcements, new presentations, potential deals. Right now is the most anxious I've ever been. We are finally within sight of the end of the beginning. The start of something novel, an actual legit novel treatment for fucking cancer. The strangest things have occurred by being in this. Who knows... this stock could one day be a real story, fucking movie...the idea of big pharmaceutical taking on the small guy, paying to have him flooded and attacked and denied over and over again. The little engine that could. That's it. That's what NWbo is, and I think it can!

$NWBO $NWBO — 11.5M+ shares traded in just two hours! Something is attracting attention, even though the price hasn’t caught up with the volume. Remember Dr. Oz mentioning on Fox News that President Trump had heard about a young brain cancer patient reportedly cured? Greta later linked that story to Braelyn, the young GBM patient treated by Dr. Linda Liau. Her reported MRI results following personalized vaccine treatment are incredibly encouraging. Pure speculation: What if Greta interviews Braelyn and her mother in a podcast about their journey, DCVax-L and Keytruda? Imagine the public awareness such a story could generate! No interview is confirmed, but the possibility is exciting. Could this be the beginning of broader recognition for DCVax-L?

$NWBO Great Point by manibiotech in ihub manibiotech Re: Kap10jak post# 844209 Friday, 10/09/2026 8:28:15 AM The situation is really weird. NHS normally comes into play after NICE has appraised and recommended NHS to cover the new drug/treatment. But if NHS is already partnering in manufacturing part of the vaccine and reporting it publicly, how at all will NICE, after the fact, recommend not covering the treatment !!! Nothing in NW world is normal ever !! 😊

$NWBO A FINAL WARNING TO RETAIL SHORT SELLERS For those betting against Northwest Biotherapeutics, the question is no longer simply whether the trade was clever. It is whether the risk remains worth taking. You may congratulate yourself on your bearish call — until the market delivers its verdict. A short position carries theoretically unlimited losses, potentially putting your entire capital and personal assets at risk if the share price surges unexpectedly. Meanwhile, the market is noticing the changes. Should a favourable regulatory announcement arrive, the market reaction could be swift and severe. Any sudden rush to cover could amplify volatility, leaving latecomers scrambling for the exit. So ask yourself one question: is the potential reward worth the risk of being caught on the wrong side of a major announcement? The train may be gathering steam. Make sure you understand the risks before deciding whether to stand in its path.

$NWBO So typical that NWBO has the spotlight at this conference and the “Rats, MM’s, and cronies smear anything positive about DCVax. Tic-TOC rats, with all the manipulation over the years I truly believe that we get approval, we are still going and soon to have an MAA in hand.

$NWBO From Smokey21 on Investorshub: I believe that they have enough data from Specials patients who had solid tumors other than GBM and seeing similar results in those cancers. I believe, enough to issue conditional approval for other than GBM. I say this also because the safety profile is so outstanding as well. They have very little to lose, and everything to gain. Think of the impact they could have on cancer in the UK because they would be cutting out the bureaucracy of additional full trials to get approval when they could be treating patients and recording that data to confirm their hypothesis. It took a Long time to get here, but I have always hoped they were swinging for the fences, ans I believe it’s about to pay off.

$NWBO and we have to quit focusing on the sellers are those who are trying to depress the stock. Look at the positives today and going forward. I’m not selling one share. You’d be a fool to do that.

If I were short $NWBO on the bet that it would go bankrupt and I'd never have to cover, this is where I'd admit that thesis is dead - and cover at pennies rather than risk covering at many dollars.

$NWBO Man o Man ! it is raining with good news ! Expect a thunderous day. Shorts are delusional and will defy and deny but we don’t give a flying f.ck do we ? 😂 😂 😂 Remember always : We Are a band of LONG Brothers and Sisters and we will take this Company, it’s Patients, it’s Scientitsts, it’s Management and Investors to total VICTORY ✌🏿 💎 🙌 HODL MOASS100

$NWBO How many naked shares did take to do that. They are just plain assholes. Still excited as all get up with today’s pr